跳至主要内容
临床试验/NCT02101255
NCT02101255已完成不适用

Effect of Curodont™ Repair in Patients With Early Approximal Carious Lesions: A Mono-centre, Controlled, Single-blinded, Randomised, Split-mouth, Post-marketing Study

Credentis AG2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2014年7月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Credentis AG
入组人数
25
试验地点
2
主要终点
Opaqueness on X-Ray

研究概览

简要总结

The purpose of this study is to evaluate the therapeutic benefit of Curodont Repair for the treatment of early approximal carious lesions compared to fluoride.

详细描述

All study participants must have two early approximal carious lesions in need of a treatment but not of an invasive treatment (split-mouth design). One lesion will be treated with Curodont Repair and one with fluoride as control. Study duration is 24 months. For assessment x-ray pictures, Diagnodent Pen and DiagnoCam is used.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Two approximal carious lesions on different teeth with at least one tooth in between
  • Both study lesions must not require an invasive treatment
  • Size and form of the lesions: the lesions must be fully visible and assessable on radiographs
  • The two carious lesions must fall into classes:
  • D2 (inner half of enamel)
  • D3 (outer part of dentine) but only if very little dentine is involved (enamel-dentine junction)
  • Able and willing to observe good oral hygiene throughout the study
  • Age ≥ 18 years and ≤ 65 years
  • Willing and able to attend the on-study visits
  • Willing and able to understand all study-related procedures
  • Written informed consent before participation in the study

排除标准

  • The two study test lesions are located on adjacent teeth
  • Fluoride varnish application < 3 months prior to study treatment
  • Tooth with numerous carious lesions
  • Evidence of tooth erosion
  • History of head and neck illnesses (e.g. head/neck cancer)
  • Any pathology or concomitant medication affecting salivary flow or dry mouth
  • Any metabolic disorders affecting bone turnover
  • Patient suffers from diabetes
  • Concurrent participation in another clinical trial
  • Women who are breast-feeding, pregnant or who plan a pregnancy during the study
  • Women of childbearing potential who declare being unwilling or unable to practice contraception such as hormonal contraceptives, sexual abstinence or intercourse with a vasectomised partner

研究组 & 干预措施

Fluoride

Active Comparator

Application on Day 0, Day 180, Day 360, Day 540

干预措施: Fluoride (Device)

Curodont Repair

Experimental

Application on Day 0 and Day 360

干预措施: Curodont Repair (Device)

结局指标

主要结局

Opaqueness on X-Ray

时间窗: Day 360

The primary efficacy outcome is the difference of the change in the opaqueness of the carious lesion on the x-ray picture from Day 0 to Day 365 between test and control group.

次要结局

  • Additional benefit of a second Curodont Repair application(Day 720)

研究者

发起方
Credentis AG
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Effect of Curodont™ Repair in Patients With Early... | 临床试验